Concepedia

Javier R. Revollo

JR

Statistics

Publications

25

Citations

2.8K

H-Index

14

Active since

2003

Affiliations

National Center for Toxicological Research(Current)

United States Food and Drug Administration

Washington University in St. Louis

Johns Hopkins University

Johns Hopkins Medicine

Javier R. Revollo is an author at National Center for Toxicological Research specializing in life sciences, molecular biology, and genetics.

ORCID

Publications per year

2003–2024

25

Publications

25

The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells

Javier R. Revollo, Andrew A. Grimm, Shin‐ichiro Imai · Journal of Biological Chemistry · 2004 · 993 citations · Full text

, , +15

Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme

Javier R. Revollo, Antje Körner, Kathryn F. Mills et al. · Cell Metabolism · 2007 · 898 citations · Full text

, , +16

Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme

Tao Wang, Xiangbin Zhang, Poonam Bheda et al. · Nature Structural & Molecular Biology · 2006 · 295 citations

, , +10

Sphingolipids are essential for differentiation but not growth in Leishmania

Kai Zhang, Melissa Showalter, Javier R. Revollo et al. · The EMBO Journal · 2003 · 122 citations · Full text

, , +10

Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing

Erica L. McGrath, Hyunsu Shin, Linyi Zhang et al. · Nature Communications · 2019 · 65 citations · Full text

, , +14

1–5 of 25